InvestLog
SABS SAB Biotherapeutics, Inc. logo

SABS SAB Biotherapeutics, Inc.

Healthcare
$3.81-2.31%ClosedMarket Cap: $36.4M

As of 2026-05-26

Forward Estimates
PeriodEPS Est.Revenue Est.# Analysts
Fri Dec 31$-0.66$50.0K5
Sun Dec 31$-0.71$7.4M7
Mon Dec 31$-0.51$81.6M2
Tue Dec 31$0.02$227.8M5